Physician

Andrija Vidic, D.O

According to 2025 Medicare claims, Andrija Vidic, D.O (NPI: 1003120692) practices advanced heart failure and transplant cardiology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is FLORIDA HOSPITAL MEDICAL GROUP INC (NPI: 1225034234; TIN: 593214635) and primary practice location at 32803-1248. Vidic is affiliated with the Centrus Health LLC (ACO ID: A5304), participating under the MSSP model.

Vidic's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 74 traditional Medicare patients, billed 440 HCPCS/CPT codes, and received $44,468 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,574 prescription claims across 322 beneficiaries totaling $423,575 in drug costs, led by Entresto (Sacubitril/Valsartan). DME data shows 285 claims. Open Payments data shows 66 records totaling $9,514. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $53,452 and ending at $44,468. Concurrently, Part D prescription costs have risen steadily, from $29,521 to $423,575. For DME billing, reported payments moved sharply higher in recent years, from $3,442 to $14,533.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	96	603	$53,452
2018	232	1,660	$147,818
2019	182	1,229	$122,747
2020	201	777	$80,893
2021	253	924	$85,603
2022	240	1,242	$107,157
2023	260	944	$70,498
2024	74	440	$44,468

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	84	469	$29,521
2016	78	541	$43,607
2017	65	288	$32,117
2018	96	726	$126,826
2019	115	941	$89,305
2020	173	1,483	$175,819
2021	260	1,302	$264,343
2022	419	2,975	$763,652
2023	509	4,691	$1,513,658
2024	322	1,574	$423,575

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	198	$12,501
2019	N/R	148	$4,100
2020	N/R	162	$5,331
2021	N/R	122	$4,244
2022	29	574	$44,243
2023	45	1,110	$84,923
2024	32	285	$12,350

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	20	68	$175
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	19	19	$132
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	23	41	$132
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	37	171	$96

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	72	3,772	$80,055
Jardiance	Empagliflozin	85	4,289	$78,854
Eliquis	Apixaban	71	3,870	$72,778
Farxiga	Dapagliflozin Propanediol	49	3,030	$52,867
Ozempic	Semaglutide	15	700	$18,263

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	12	$3,919
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	28	$3,097
J2260	Injection, milrinone lactate, 5 mg	N	N/R	28	$1,350
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	21	$849
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	18	44	$790

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	66	$9,514	ABIOMED
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrija Vidic, D.O?

Tedicare shows public-source Medicare data for Andrija Vidic, D.O (NPI 1003120692), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrija Vidic, D.O have ACO affiliation data?

Andrija Vidic, D.O is shown with ACO affiliation data for Centrus Health LLC (MSSP, ACO ID A5304).

What billing organization is linked to Andrija Vidic, D.O?

Andrija Vidic, D.O is linked to FLORIDA HOSPITAL MEDICAL GROUP INC (billing NPI 1225034234) in the available physician profile data.

Does Andrija Vidic, D.O have Open Payments data?

Andrija Vidic, D.O has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.